Company
Wheeler Bio
Wheeler Bio is a High-Science, High-Touch biologics CDMO advancing antibody-based therapeutics from discovery to the clinic and beyond.
Also known as WHEELER BIO, INC.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Oklahoma City, OK, United States
- Customers
- Innovator, a CRO, or a CDMO
- Legal name
- WHEELER BIO, INC.
- wheelerbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Wheeler Bio is a biologics CDMO specializing in antibody-based therapeutics, offering services from discovery through cGMP clinical supply.
Funding snapshot
- Total raised
- $59.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A2025-03-20
Funding rounds
- Round, 2025
- $23.1M2025-03-04, SEC form D sold, 18 investors
- Round, 2022
- $23.2M2022-09-16, SEC form D sold, 8 investors
- Round, 2021
- $13.6M2021-11-08, SEC form D sold, 10 investors
Products
- Other
- ModularCMC
Loading relationship preview